Citigroup’s Tenon Medical TNON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49
Closed -$564 – 6303
2026
Q2
$564 Sell
49
-233
-83% -$5.6K ﹤0.01% 5454
2026
Q1
$7.15K Buy
+282
New +$8.3K ﹤0.01% 5156
2025
Q4
– Sell
-1
Closed -$40 – 5993
2025
Q3
$51 Buy
+1
New +$42 ﹤0.01% 5851
2025
Q2
– Sell
-3
Closed -$253 – 5904
2025
Q1
$253 Buy
+3
New +$169 ﹤0.01% 5408
2024
Q4
– Hold
0
– -$4 – 5959
2024
Q3
– Hold
0
– – – 5640
2024
Q2
– Hold
0
– – – 5552
2024
Q1
– Hold
0
– – – 5607
2023
Q4
– Hold
0
– – – 5663
2023
Q3
– Hold
0
– – – 5648
2023
Q2
– Hold
0
– – – 5548
2023
Q1
– Hold
0
– – – 5287
2022
Q4
– Hold
0
– – – 5645
2022
Q3
– Sell
-1
Closed -$5.83K – 6319
2022
Q2
$3K Buy
+1
New +$29.1K ﹤0.01% 5804

Other funds holding TNON

Citigroup's TNON Position: Q3 2026 in Review

Citigroup sold out of Tenon Medical (TNON) in Q3 2026, closing a stake of 49 shares — an estimated $564 sold.

Citigroup first reported a position in TNON in Q2 2022 and held it in 5 quarters. The position peaked at $7.15K in Q1 2026. 6 funds tracked by Wall St. Rank hold TNON as of Q3 2026.

  • Citigroup reported no remaining Tenon Medical position as of Q3 2026 after selling out during the quarter.
  • Citigroup sold 49 Tenon Medical shares in Q3 2026, an estimated $564.
  • Citigroup first reported a position in Tenon Medical in Q2 2022 and held it in 5 quarters.
  • Citigroup's Tenon Medical position peaked at $7.15K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Tenon Medical as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.